Article
03 Apr 2020
COVID-19 Emergency Response Act: Amendments To The Patent Act
Jennifer Wilkie
Popular Topics
AUTHORS CONTENT
Article
09 Oct 2018
The USMCA: What Does It Mean For Patents And The Pharmaceutical Industry?
Article
27 Dec 2017
The Skinny On Skinny Labels
Article
18 May 2017
What The Supreme Court Of Canada Was Not Told About Patent Utility
Article
11 Feb 2016
Changes At PMPRB To Safeguard Against Excessively Priced Medicines
Article
21 Jan 2016
Health Canada Seeks Comment On Revised SEB Guidance Document: New Requirements For SEB Sponsors
Article
03 Jul 2015
PM(NOC) Regulation Amendments Now In Force
Article
11 May 2015
Industry Canada Seeks Comment On Proposed Changes To Listing Requirements Under The PM(NOC) Regulations
Article
02 Feb 2015
Federal Court Rejects NIA Defence And Awards Compound Interest On Patent Damages
Article
19 Jan 2015
Federal Court Determines Minister’s Decisions Granting NOCs Based On Administrative ANDSs Cross-Referencing Licensed Generics Without Requiring NOAs Are Wrong
Article
26 Feb 2014
Pharmacapsules @ Gowlings: February 21, 2014 - Volume 13, Number 3
Article
27 Nov 2013
Supreme Court Upholds Ontario Restrictions On Formulary Listing Of Private Label Products
Article
13 May 2013
Utility, Sound Prediction And Promise Of The Patent
Article
13 May 2013
Federal Court Rejects PMPRB Copaxone Decision On Excessive Prices – Again
Article
26 Feb 2013
Court Affirms Utility Of Gleevec Patent
Article
04 Jul 2012
Data Protection: A Viable Alternative To Patent Protection?
Article
29 Apr 2012
Pharmacapsules @ Gowlings: April 13, 2012
Article
18 Apr 2012
Pharmacapsules @ Gowlings: April 11, 2012 - Volume 11, Number 5
Article
13 Apr 2012
Pharmacapsules @ Gowlings: April 3, 2012 - Volume 11, Number 4
Article
09 Feb 2012
Pharmacapsules @ Gowlings - February 3, 2012 - Volume 11, Number 2